Home » Topics » BioWorld Science

BioWorld Science
RSS

EPRS inhibitor DWN-12088 shows antifibrotic effects in vitro and in vivo

Sep. 15, 2021

Preclinical data presented for HIF-1 inhibitor LW-1564

Sep. 15, 2021

Kinnate presents preclinical data on next-generation pan-FGFR inhibitor KIN-3248

Sep. 14, 2021

Satellos reports preclinical data on drug candidate in mouse model of DMD

Sep. 14, 2021

Strong nectin-4 expression tied to poor prognosis in UTUC

Sep. 14, 2021

SQZ announces celiac disease as first autoimmune clinical translation of TAC platform

Sep. 14, 2021

vTv Therapeutics discloses glucokinase activators

Sep. 14, 2021

Beta Pharma presents new GTPase KRAS mutant inhibitors

Sep. 14, 2021

Tempest Therapeutics licenses intellectual property to cancer target from University of California

Sep. 14, 2021

Discovery of apigenin derivative with potential to overcome drug-resistant MET-mutant RCC

Sep. 14, 2021

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.